drugset / Trial / NCT06923787

Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study

NCT06923787

Phase 2 Recruiting 100 enrolled Institute of Oncology Ljubljana
RandomizedParallel-groupTriple-blindTreatment

Summary

There are very few data in the literature on changes in inflammatory markers when lidocaine is administered perioperatively in patients with colorectal cancer. In patients undergoing surgery for colon cancer, the aim is to conduct a double-blind placebo-controlled study to determine differences in levels of pro-inflammatory markers, postoperative pain and opioid analgesic consumption in the first two days after surgery, and the time to first postoperative bowel movement. Groups of patients receiving perioperative lidocaine infusion, high dose dexamethasone or placebo will be compared.

Timeline

Start
2026-02-03
Primary completion
2027-07-01
Completion
2028-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified Intravenous

Indications